Furthermore, the SNHG26‐CDKN2A axis modulated the tumour immune microenvironment by regulating CD8+ T cell cytotoxicity and chemokine expression, specifically downregulating CXCL9 and CXCL10, which are critical for T cell recruitment. This evidence concerns the gene CXCL10 and neoplasm.